R A Hanisch1, P S Sow, M Toure, A Dem, B Dembele, P Toure, R L Winer, J P Hughes, G S Gottlieb, Q Feng, N B Kiviat, S E Hawes. 1. Department of Epidemiology, School of Public Health, University of Washington, Box 357236, Seattle, WA 98195, USA; International Agency for Research on Cancer, Section of Environment and Radiation, 150 Cours Albert Thomas, Lyon, 69372 Cedex 08, France. Electronic address: hanischr@fellows.iarc.fr.
Abstract
BACKGROUND: HIV infection is associated with greater risk of precancerous lesions and cervical cancer in women. However, several factors remain unclarified regarding the association between HIV infection and HPV detection, especially among those with HIV type 2 versus type 1 infection and severely immunocompromised persons. OBJECTIVES: To evaluate HPV overall and type-specific detection among HIV-infected and uninfected women in Senegal. STUDY DESIGN: Detection of HPV DNA for 38 genotypes in cervical swabs using PCR-based methods was evaluated in HIV-positive (n=467) and HIV-negative (n=2139) women participating in studies in Senegal. Among HIV-1 and/or HIV-2 positive women, CD4 counts were assessed. Adjusted multivariable prevalence ratios (PR) were calculated. RESULTS: The prevalence of any HPV DNA and multiple HPV types was greater among HIV-infected individuals (78.2% and 62.3%, respectively) compared with HIV-negative women (27.1% and 11.6%). This trend was also seen for HPV types 16 and 18 (13.1% and 10.9%) compared to HIV-negative women (2.2% and 1.7%). HIV-infected women with CD4 cell counts less than 200 cells/μl had a higher likelihood of any HPV detection (PRa 1.30; 95% CI 1.07-1.59), multiple HPV types (PRa 1.52; 95% CI 1.14-2.01), and HPV-16 (PRa 9.00; 95% CI 1.66-48.67), but not HPV-18 (PRa 1.20, 95% CI 0.45-3.24) compared to those with CD4 counts 500 cells/μl or above. CONCLUSION: HIV-infected women, especially those most severely immunocompromised, are more likely to harbor HPV. Measures to prevent initial HPV infection and subsequent development of cervical cancer through focused screening efforts should be implemented in these high risk populations.
BACKGROUND:HIV infection is associated with greater risk of precancerous lesions and cervical cancer in women. However, several factors remain unclarified regarding the association between HIV infection and HPV detection, especially among those with HIV type 2 versus type 1 infection and severely immunocompromised persons. OBJECTIVES: To evaluate HPV overall and type-specific detection among HIV-infected and uninfected women in Senegal. STUDY DESIGN: Detection of HPV DNA for 38 genotypes in cervical swabs using PCR-based methods was evaluated in HIV-positive (n=467) and HIV-negative (n=2139) women participating in studies in Senegal. Among HIV-1 and/or HIV-2 positive women, CD4 counts were assessed. Adjusted multivariable prevalence ratios (PR) were calculated. RESULTS: The prevalence of any HPV DNA and multiple HPV types was greater among HIV-infected individuals (78.2% and 62.3%, respectively) compared with HIV-negative women (27.1% and 11.6%). This trend was also seen for HPV types 16 and 18 (13.1% and 10.9%) compared to HIV-negative women (2.2% and 1.7%). HIV-infectedwomen with CD4 cell counts less than 200 cells/μl had a higher likelihood of any HPV detection (PRa 1.30; 95% CI 1.07-1.59), multiple HPV types (PRa 1.52; 95% CI 1.14-2.01), and HPV-16 (PRa 9.00; 95% CI 1.66-48.67), but not HPV-18 (PRa 1.20, 95% CI 0.45-3.24) compared to those with CD4 counts 500 cells/μl or above. CONCLUSION:HIV-infectedwomen, especially those most severely immunocompromised, are more likely to harbor HPV. Measures to prevent initial HPV infection and subsequent development of cervical cancer through focused screening efforts should be implemented in these high risk populations.
Authors: J M Palefsky; H Minkoff; L A Kalish; A Levine; H S Sacks; P Garcia; M Young; S Melnick; P Miotti; R Burk Journal: J Natl Cancer Inst Date: 1999-02-03 Impact factor: 13.506
Authors: Qinghua Feng; Akhila Balasubramanian; Stephen E Hawes; Papa Toure; Papa Salif Sow; Ahmadou Dem; Birama Dembele; Cathy W Critchlow; Longfu Xi; Hiep Lu; Martin W McIntosh; Alicia M Young; Nancy B Kiviat Journal: J Natl Cancer Inst Date: 2005-02-16 Impact factor: 13.506
Authors: Stephen E Hawes; Cathy W Critchlow; Papa Salif Sow; Papa Touré; Ibraham N'Doye; Aissatou Diop; Jane M Kuypers; Abdoul A Kasse; Nancy B Kiviat Journal: J Natl Cancer Inst Date: 2006-01-18 Impact factor: 13.506
Authors: C L Langley; E Benga-De; C W Critchlow; I Ndoye; M D Mbengue-Ly; J Kuypers; G Woto-Gaye; S Mboup; C Bergeron; K K Holmes; N B Kiviat Journal: AIDS Date: 1996-04 Impact factor: 4.177
Authors: L S Massad; K A Riester; K M Anastos; R G Fruchter; J M Palefsky; R D Burk; D Burns; R M Greenblatt; L I Muderspach; P Miotti Journal: J Acquir Immune Defic Syndr Date: 1999-05-01 Impact factor: 3.731
Authors: N Muñoz; F X Bosch; S de Sanjosé; L Tafur; I Izarzugaza; M Gili; P Viladiu; C Navarro; C Martos; N Ascunce Journal: Int J Cancer Date: 1992-11-11 Impact factor: 7.396
Authors: Katundu Katundu; Allen C Bateman; Krista S Pfaendler; Mulindi H Mwanahamuntu; Sharon Kapambwe; Sten H Vermund; Vikrant V Sahasrabuddhe; Susan C Msadabwe; Jeffrey S A Stringer; Groesbeck P Parham; Carla J Chibwesha Journal: J Low Genit Tract Dis Date: 2015-10 Impact factor: 1.925
Authors: Hilary K Whitham; Stephen E Hawes; Haitao Chu; J Michael Oakes; Alan R Lifson; Nancy B Kiviat; Papa Salif Sow; Geoffrey S Gottlieb; Selly Ba; Marie P Sy; Shalini L Kulasingam Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-05-17 Impact factor: 4.254
Authors: Luana L S Rodrigues; Mariza G Morgado; Vikrant V Sahasrabuddhe; Vanessa S De Paula; Nathália S Oliveira; Elena Chavez-Juan; Diane M Da Silva; W Martin Kast; Alcina F Nicol; José H Pilotto Journal: Gynecol Oncol Date: 2018-08-04 Impact factor: 5.482
Authors: Jessica L Castilho; José Eduardo Levi; Paula M Luz; Mary Catherine Cambou; Tazio Vanni; Angela de Andrade; Mônica Derrico; Valdiléa G Veloso; Beatriz Grinsztejn; Ruth K Friedman Journal: BMC Cancer Date: 2015-06-23 Impact factor: 4.430
Authors: Sally N Akarolo-Anthony; Ayo O Famooto; Eileen O Dareng; Olayinka B Olaniyan; Richard Offiong; Cosette M Wheeler; Clement A Adebamowo Journal: BMC Public Health Date: 2014-06-27 Impact factor: 3.295
Authors: Fidele Ngabo; Silvia Franceschi; Iacopo Baussano; M Chantal Umulisa; Peter J F Snijders; Anne M Uyterlinde; Fulvio Lazzarato; Vanessa Tenet; Maurice Gatera; Agnes Binagwaho; Gary M Clifford Journal: BMC Infect Dis Date: 2016-05-24 Impact factor: 3.090